Foghorn Therapeutics Inc. (FHTX) Operating Income (Loss) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Foghorn Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
  • Foghorn Therapeutics Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$28.2 M, a 15.4% increase year-over-year.
  • Foghorn Therapeutics Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$103 M, a 16.2% increase year-over-year.
  • Foghorn Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$108 M, a 7.88% increase from 2022.
  • Foghorn Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$117 M, a 16.3% decline from 2021.
  • Foghorn Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$101 M, a 47% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$103 M -$28.2 M +$5.12 M +15.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$108 M -$25.5 M +$6.43 M +20.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$114 M -$17.1 M +$11.2 M +39.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$126 M -$32.1 M -$2.86 M -9.81% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 -$123 M -$33.3 M -$5.51 M -19.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$117 M -$31.9 M -$3.8 M -13.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$113 M -$28.3 M -$2 M -7.61% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$111 M -$29.2 M -$5.93 M -25.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$105 M -$27.8 M -$4.67 M -20.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$101 M -$28.1 M -$7.3 M -35.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$93.4 M -$26.3 M -$7.77 M -42% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$85.7 M -$23.3 M -$7.72 M -49.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$77.9 M -$23.1 M -$9.41 M -68.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$68.5 M -$20.8 M Oct 1, 2020 Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 -$18.5 M -$5.39 M -41.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$15.5 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$13.7 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 -$13.1 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.